Introduction: Breathe Well-being Diabetes Reversal Program (BDRP) provides personalized Lifestyle Management (LSM) including coaching on diet and exercise as needed by individuals with type 2 diabetes mellitus (T2DM) along with tracking their blood glucose levels, weight, and physical activity.

Objective: To evaluate the effectiveness of BDRP for achieving remission in individuals with T2DM in India.

Methodology: This observational study had three cohorts (1:1:1) who were treated with: (1) BDRP with doctor-prescribed medication, (2) BDRP with doctor-prescribed medication and personalized stress reduction module, and (3) Only doctor-prescribed medication (control group) . Program adherence level was categorized as high (H: >70%) , medium (M: ≥50%-<70%) , and low (L: <50%) ; H and M data of cohorts 1 and 2 are presented here. Program was provided for 4 months, and individuals followed up at 7, 10, 13, 16, and 19 months. Informed consent was obtained.

Results: The study included 181 individuals with an average age of 53.1 years, of which 1 (55.8%) were male. Overall, 46.7% (28) and 54.1% (33) individuals in cohorts 1 and 2 showed H and M adherence. Cohorts 1 and 2 showed 1.0% and 1.3% average HbA1c reduction vs. 0.3% with cohort 3 (overall population) after 4 months. At 4 months, in cohort 1, HbA1c levels <6.5% were observed in 32.1% individuals, which increased to 60.7%, 67.9%, and 78.6% at 7, 10, and 19 months vs. 36.4% individuals in cohort 2, which increased to 51.5%, 69.7%, and 81.8% at 7, 10, and 19 months, respectively. In cohorts 1 and 2, medication withdrawal was observed in 89.3% and 90.9% individuals at 13 months which was maintained up to 19 months.

Conclusion: BDRP was effective in achieving remission in individuals with T2DM in India. BDRP with personalized stress reduction module had better outcomes comparatively. Digital therapeutics could be a potential approach in achieving diabetes remission in Indian settings.

Disclosure

P.K.Goyal: None. S.K.Patra: Employee; Breathe Well-being. A.Kaicker: None. R.Verma: None. S.Goel: Employee; Breathe Well-being. S.Rehman: None. R.Jangid: None. V.Madhusudhana: None.

© 2022 by the American Diabetes Association
2022
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.